Debra L. Barton

12.3k total citations · 5 hit papers
163 papers, 8.4k citations indexed

About

Debra L. Barton is a scholar working on Oncology, Endocrinology, Diabetes and Metabolism and Genetics. According to data from OpenAlex, Debra L. Barton has authored 163 papers receiving a total of 8.4k indexed citations (citations by other indexed papers that have themselves been cited), including 69 papers in Oncology, 48 papers in Endocrinology, Diabetes and Metabolism and 32 papers in Genetics. Recurrent topics in Debra L. Barton's work include Menopause: Health Impacts and Treatments (40 papers), Cancer survivorship and care (37 papers) and Cancer Treatment and Pharmacology (33 papers). Debra L. Barton is often cited by papers focused on Menopause: Health Impacts and Treatments (40 papers), Cancer survivorship and care (37 papers) and Cancer Treatment and Pharmacology (33 papers). Debra L. Barton collaborates with scholars based in United States, Vietnam and Canada. Debra L. Barton's co-authors include Charles L. Loprinzi, Jeff A. Sloan, Paul J. Novotny, Beth LaVasseur, Sherry L. Wolf, Deirdre R. Pachman, Lisa A. Kottschade, Bradley J. Christensen, Axel Grothey and Shaker R. Dakhil and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Cancer.

In The Last Decade

Debra L. Barton

160 papers receiving 8.0k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Venlafaxine in management of hot flashes in survivors of breast cancer: a randomised controlled trial

2000 539 citations Charles L. Loprinzi, John W. Kugler et al. The Lancet profile →
Endocrine Therapy for Hormone Receptor–Positive Metastatic Breast Cancer: American Society of Clinical Oncology Guideline

2016 446 citations Debra L. Barton et al. Journal of Clinical Oncology profile →
Integrative Medicine for Pain Management in Oncology: Society for Integrative Oncology–ASCO Guideline

2022 139 citations Debra L. Barton, Thomas W. LeBlanc et al. Journal of Clinical Oncology profile →
Use of Opioids for Adults With Pain From Cancer or Cancer Treatment: ASCO Guideline

2022 109 citations Judith A. Paice, Kari Bohlke et al. Journal of Clinical Oncology profile →
Management of Fatigue in Adult Survivors of Cancer: ASCO–Society for Integrative Oncology Guideline Update

2024 52 citations Julienne E. Bower, Christina Lacchetti et al. Journal of Clinical Oncology profile →

Peers

Countries citing papers authored by Debra L. Barton

Since Specialization

Citations

This map shows the geographic impact of Debra L. Barton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Debra L. Barton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Debra L. Barton more than expected).

Fields of papers citing papers by Debra L. Barton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Debra L. Barton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Debra L. Barton. The network helps show where Debra L. Barton may publish in the future.

Co-authorship network of co-authors of Debra L. Barton

This figure shows the co-authorship network connecting the top 25 collaborators of Debra L. Barton. A scholar is included among the top collaborators of Debra L. Barton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Debra L. Barton. Debra L. Barton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Management of Fatigue in Adult Survivors of Cancer: ASCO–Society for Integrative Oncology Guideline Update breakdown → 2024 ·Journal of Clinical Oncology ·Julienne E. Bower, Christina Lacchetti, Yesne Alici, Debra L. Barton, Deborah Watkins Bruner, Beverly Canin, Carmelita P. Escalante, Patricia A. Ganz, Sheila N. Garland, Shilpi Gupta, Heather Jim, Jennifer A. Ligibel, Kah Poh Loh, Luke J. Peppone, Debu Tripathy, Sriram Yennu, Suzanna M. Zick, Karen M. Mustian	52
2	A descriptive study of policy and system-level interventions to address cancer survivorship issues across six United States health systems 2023 ·Journal of Cancer Survivorship ·Martha Quinn, (unknown), (unknown), Debra L. Barton, Marita G. Titler, Julie Armin, Michelle J. Naughton, Jennifer Wenzel, Sanja Percac‐Lima, Pooja Mishra, (unknown), Christopher R. Friese	1
3	Implementing patient navigation programs: Considerations and lessons learned from the Alliance to Advance Patient‐Centered Cancer Care 2022 ·Cancer ·Elizabeth S. Ver Hoeve, Melissa A. Simon, (unknown), (unknown), (unknown), Sanja Percac‐Lima, (unknown), Electra D. Paskett, Michelle J. Naughton, Darrell M. Gray, Jennifer Wenzel, James Zabora, Ahmed Hassoon, (unknown), Elizabeth A. Calhoun, Debra L. Barton, Christopher R. Friese, Marita G. Titler, Heidi Hamann	10
4	Use of Opioids for Adults With Pain From Cancer or Cancer Treatment: ASCO Guideline breakdown → 2022 ·Journal of Clinical Oncology ·Judith A. Paice, Kari Bohlke, Debra L. Barton, David S. Craig, Areej El‐Jawahri, Dawn L. Hershman, (unknown), Geana Paula Kurita, Thomas W. LeBlanc, Sebastiano Mercadante, (unknown), Ramy Sedhom, Carole Seigel, (unknown), Éduardo Bruera	109
5	Randomized Controlled Phase II Evaluation of Two Dose Levels of Bupropion Versus Placebo for Sexual Desire in Female Cancer Survivors: NRG-CC004 2021 ·Journal of Clinical Oncology ·Debra L. Barton, Stephanie L. Pugh, Patricia A. Ganz, Steven C. Plaxe, Bridget F. Koontz, Jeanne Carter, (unknown), (unknown), Kendrith M. Rowland, Ernie Balcueva, (unknown), Jack Basil, (unknown), Carolyn Y. Muller, Maria C. Bell, Snehal Deshmukh, Lisa A. Kachnic	12
6	Promoting Health and Well-Being Through Mobile Health Technology (Roadmap 2.0) in Family Caregivers and Patients Undergoing Hematopoietic Stem Cell Transplantation: Protocol for the Development of a Mobile Randomized Controlled Trial 2020 ·JMIR Research Protocols ·(unknown), (unknown), (unknown), Afton L. Hassett, Thomas Braun, Debra L. Barton, Noelle E. Carlozzi, Srijan Sen, Muneesh Tewari, David A. Hanauer, Sung Won Choi	17
7	A Mobile Health App (Roadmap 2.0) for Patients Undergoing Hematopoietic Stem Cell Transplant: Qualitative Study on Family Caregivers' Perspectives and Design Considerations 2019 ·JMIR mhealth and uhealth ·(unknown), Ji Youn Shin, (unknown), (unknown), (unknown), (unknown), David A. Hanauer, Debra L. Barton, Afton L. Hassett, Sung Won Choi	21
8	Complementary therapies for fatigue after hematopoietic stem cell transplantation: an integrative review 2018 ·Bone Marrow Transplantation ·Mohamad Baydoun, Debra L. Barton	10
9	Developing a Hypnotic Relaxation Intervention to Improve Body Image: A Feasibility Study 2016 ·Oncology nursing forum ·(unknown), Gary Elkins, Tanima Banerjee, (unknown), (unknown), Alisa J. Johnson, (unknown), Debra L. Barton	6
10	Sternal skin conductance 2013 ·Menopause The Journal of The North American Menopause Society ·Deirdre R. Pachman, Charles L. Loprinzi, Paul J. Novotny, Daniel Satele, Breanna M. Linquist, Sherry L. Wolf, Debra L. Barton	6
11	The use of Ginkgo biloba for the prevention of chemotherapy-related cognitive dysfunction in women receiving adjuvant treatment for breast cancer, N00C9 2012 ·Supportive Care in Cancer ·Debra L. Barton, Kelli N. Burger, Paul J. Novotny, Tom R. Fitch, Sadhna Kohli, Gamini S. Soori, Mary B. Wilwerding, Jeff A. Sloan, Lisa A. Kottschade, Kendrith M. Rowland, Shaker R. Dakhil, Daniel A. Nikcevich, Charles L. Loprinzi	43
12	The relationship between numbness, tingling, and shooting/burning pain in patients with chemotherapy-induced peripheral neuropathy (CIPN) as measured by the EORTC QLQ-CIPN20 instrument, N06CA 2011 ·Supportive Care in Cancer ·Sherry L. Wolf, Debra L. Barton, Rui Qin, Edward J. Wos, Jeff A. Sloan, Heshan Liu, Neil K. Aaronson, Daniel Satele, Bassam Mattar, (unknown), Charles L. Loprinzi	97
13	A phase III randomized, double-blind, placebo-controlled trial of gabapentin in the management of hot flashes in men (N00CB) 2009 ·Annals of Oncology ·Charles L. Loprinzi, (unknown), (unknown), Debra L. Barton, (unknown), Kendrith M. Rowland, Philip J. Atherton, Gerald W. Marsa, (unknown), James D. Bearden, Lisa A. Kottschade, Tom R. Fitch	48
14	Mayo Clinic and North Central Cancer Treatment Group hot flash studies 2008 ·Menopause The Journal of The North American Menopause Society ·Charles L. Loprinzi, Debra L. Barton, Jeff A. Sloan, Paul J. Novotny, Shaker R. Dakhil, (unknown), (unknown), Joseph Kelaghan, Brad Christensen	48
15	Phase II Evaluation of Desipramine for the Treatment of Hot Flashes 2007 ·PubMed ·Debra L. Barton, Charles L. Loprinzi, Philip J. Atherton, Jane M. Raymond, Tait D. Shanafelt, Stephanie L. Hines, (unknown), Teresa A. Rummans, Alex A. Adjei, Jeff A. Sloan	7
16	Phase III Comparison of Depomedroxyprogesterone Acetate to Venlafaxine for Managing Hot Flashes: North Central Cancer Treatment Group Trial N99C7 2006 ·Journal of Clinical Oncology ·Charles L. Loprinzi, Ralph Levitt, Debra L. Barton, Jeff A. Sloan, Shaker R. Dakhil, Daniel A. Nikcevich, James D. Bearden, James A. Mailliard, Loren K. Tschetter, Tom R. Fitch, John W. Kugler	86
17	Venlafaxine in management of hot flashes in survivors of breast cancer: a randomised controlled trial breakdown → 2000 ·The Lancet ·Charles L. Loprinzi, John W. Kugler, (unknown), James A. Mailliard, Beth LaVasseur, Debra L. Barton, Paul J. Novotny, Shaker R. Dakhil, (unknown), Teresa A. Rummans, Bradley J. Christensen	539
18	Prospective evaluation of vitamin E for hot flashes in breast cancer survivors. 1998 ·Journal of Clinical Oncology ·Debra L. Barton, Charles L. Loprinzi, Susan K. Quella, Jeff A. Sloan, M H Veeder, James R. Egner, (unknown), Philip J. Stella, (unknown), Nancy L. Vaught, Paul Novotny	288
19	A randomized, crossover evaluation of methylphenidate in cancer patients receiving strong narcotics 1995 ·Supportive Care in Cancer ·Mary B. Wilwerding, Charles L. Loprinzi, James A. Mailliard, Judith R. OʼFallon, Angela W. Miser, (unknown), Debra L. Barton, John Foley, (unknown)	88
20	Amniotic Fluid Ingestion Enhances \nOpioid-Mediated But Not \nNonopioid-Mediated Analgesia 1990 ·CogPrints (University of Southampton) ·Mark B. Kristal, (unknown), Debra L. Barton	26

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact